Evidence map›Paper›PMID 36880025›Full record

ArticleVaccine: X2023

Health care workers' reactions to the newly introduced hepatitis B vaccine in Kalulushi, Zambia: Explained using the 5A taxonomy.

Mwiza Nyasa, Jenala Chipungu, Mwila Ngandu, Chansa Chilambe, Herbert Nyirenda, Kalo Musukuma, Mwila Lundamo, Michelo Simuyandi, Roma Chilengi, Anjali Sharma

Abstract read
In one paragraph

Article in Vaccine: X, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mwiza NyasaSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Jenala ChipunguSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Mwila NganduSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Chansa ChilambeSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Herbert NyirendaSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Kalo MusukumaEnteric Disease and Vaccine Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Mwila LundamoSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Michelo SimuyandiSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Roma ChilengiSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.
Anjali SharmaSocial and Behavioural Science Unit, Research Department, Centre for Infectious Disease Research in Zambia (CIDRZ), Lusaka, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hepatitis B virus (HBV) is highly infectious and deadly disease that is transmitted through blood and body fluids. Health care workers (HCWs) have a high risk of contracting HBV in health care settings, the Hep-B vaccine one of the recommended prevention intervention/tools. However, uptake of the vaccine among HCWs remains low in Sub-Saharan Africa. We aimed to explore the barriers and facilitators to uptake of the vaccine offered free of charge to HCWs and nursing students in Kalulushi district, Copperbelt Province of Zambia. Methods: A total of 29 in-depth interviews (IDIs), either in person or via telephone, with participants before and after they received the vaccines were used to collect the data. We analysed the barriers and facilitators to full or partial vaccination using Penchasky and Thomas's (1981) 5A's (Access, Affordability, Awareness, Acceptance and Activation) taxonomy framework for vaccine hesitancy. Results: All participants had access to the vaccine, and it was free of charge, making it affordable. Regarding awareness, all participants were aware of HBV infection as an occupational hazard, however, HCWs felt that more sensitization would be needed to increase awareness and knowledge of the vaccine. Acceptability of the vaccine was high among all completers and some non-completers as they felt it was safe and offered them protection. One non-completer felt coerced to accept the first dose due to supervisor expectations and would have preferred to have been given more time to decide. Most felt that vaccination should be compulsory for HCWs. Lastly, activation (vaccine uptake) among non-completers was hindered by late or no notification of appointments as the main reason for not completing the full vaccination schedule. HCWs advised that for countrywide roll-out, at least one weeks' notification would be necessary for HCWs to plan and be mentally prepared to be at their workstations when the vaccination is taking place. Conclusions: The need to offer the vaccine free of charge locally to ensure easy access and affordability is essential to increase vaccine uptake. Vaccination policies and guidelines for health workers, ongoing training and knowledge sharing are required. Involving trained champions in the facility can also help encourage HCWs to get vaccinated.

Indexed as

5A TaxonomyHealthcare workersHepatitis BHesitancyVaccine

Identifiers

PMID36880025
PMCPMC9985005

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.